In This Issue:
Antitrust | Compliance | Corporate | Data Privacy & Cybersecurity | Foreign Investment
This China Newsletter provides an overview of key Q2 2025 developments in the following areas:
1. Antitrust
- Latest Development in China’s Anti-Unfair Competition Law
2. Compliance
- The SAMR Issues Medical Advertising Supervision Guidelines
3. Corporate
- China Further Clarifies Rules on Using Reserve Funds and Non-Monetary Capital Contribution
4. Data Privacy & Cybersecurity
- The CAC Released Draft Amendment to the Cybersecurity Law for Public Comment
- The TC260 Releases Two Compliance Guidelines for Personal Information Protection Audit
- China’s Central Bank Releases New Data Security Regulation
- New National Standards for Sensitive Personal Information Processing
- China Proposes Updated Regulations on Exporting Automobile-Generated Data
5. Foreign Investment
- Three Authorities Jointly Issue the Market Access Negative List (2025 Edition)
- China Proposes New Foreign Exchange Policies to Boost Cross-Border Investment and Financing
- China’s New Tax Incentive Policy for Foreign Investors’ Domestic Reinvestment